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ultivating Prognosis
ollowing Percutaneous
oronary Intervention
he American College of Cardiology/
ational Cardiovascular Data Registry
isk Score*
ean J. Kereiakes, MD
incinnati, Ohio
“It appears to me a most excellent thing for the
physician to cultivate prognosis. . .by seeing and
announcing beforehand those who will live and
those who will die, he will thus escape censure.”
—Hippocrates, Aphorisms, II.19 (1)
Since the introduction of coronary balloon angioplasty,
ignificant evolution in catheter-based technologies and
djunctive pharmacotherapies has occurred, which has en-
anced safety and improved both immediate as well as
ong-term outcomes of percutaneous coronary intervention
PCI) procedures. Although PCI complications have de-
lined over time, there remains a small but definite risk of
eriprocedural mortality. Estimation of this risk may be
seful to inform clinical judgment of the treating physician,
dvise consent of the patient, enhance institutional quality
ssurance programs, assure appropriate adjustment of pro-
ider outcomes metrics, and facilitate comparative effective-
ess analyses.
See page 1923
isk Model Construct
CI outcomes have traditionally been stratified by hierar-
hical importance as death, nonfatal myocardial infarction
MI), nonfatal stroke, the requirement for repeat revascu-
arization (PCI or coronary bypass graft surgery), and
ngiographic as well as clinical procedural success. The time
ourse for outcomes assessment may be periprocedural/in-
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Christ Hospital Heart and Vascular Center/The Lindner Research
enter at The Christ Hospital, Cincinnati, Ohio. Dr. Kereiakes has received research
nd/or grant support from Abbott Vascular, Cordis/Johnson & Johnson, Bostonr
cientific, and Medtronic, and consulting fees from Boston Scientific and Abbott
ascular.ospital, 30-day or more prolonged (1 year). The predic-
ive accuracy of individual risk models may vary as a
unction of both the outcome(s) of interest as well as the
ime course for observation.
Variables analyzed and correlated with the outcome of
nterest should be specific to the population under study.
or example, clinical and angiographic variables obtained
rom a larger cohort of patients undergoing diagnostic
oronary angiography may have limited applicability to
utcomes assessed following the subsequent performance of
CI in a small portion of patients. If the ultimate goal is to
tratify risk following PCI, the mere selection of patients for
PCI procedure likely selects (or rejects) specific clinical
nd/or angiographic variables and thus alters the broader
rofile of patients from whom the predictive variables were
riginally obtained. Indeed, when pre-catheterization vari-
bles largely derived from a population that does not
ndergo PCI are correlated with outcomes following PCI,
he risk score model may be applied to a population that
annot be accurately identified prior to catheterization.
Finally, specific variables included in the risk model must
e easily and accurately defined. In the era of balloon
ngioplasty, procedural risk models focused on angiographic
esion assessment. The American College of Cardiology/
merican Heart Association (ACC/AHA) coronary lesion
lassification scheme defined 11 angiographic variables that
ere correlated with in-hospital occurrence of a composite
linical end point (death, MI, urgent coronary artery bypass
raft surgery, and procedural success) (2). The major limi-
ations of this classification scheme included subjective
ngiographic lesion assessment with considerable interob-
erver variability as well as the exclusion of important
atient-related variables that may influence PCI procedural
utcome (3). Ideally, variables employed should be limited
n number, objective, and easily obtained with a high degree
f intraobserver and interobserver correlation on repeated
easurements. Binary variables that involve integer and/or
dditive scales rather than complex mathematical equations
re optimal use in practice.
isk Prediction: A Historical Perspective
n general, clinical variables are best at predicting clinical
nd points, such as death or MI, whereas angiographic
ariables are more predictive of angiographic and/or clinical
rocedural success as well as the likelihood of restenosis or
he subsequent requirement for revascularization procedures
4). Pre-PCI variables previously correlated with risk of
eath in-hospital and up to 1-year follow-up have included
ge, hemodynamic instability, clinical heart failure, and
enal insufficiency as well as the acuity of both clinical
resentation and the procedure (5–7). The EuroSCORE,
hich is comprised of 17 patient-, cardiac-, and surgical
rocedure-related variables was originally developed to pre-
ict perioperative mortality risk following surgical coronary
evascularization (8), and has also demonstrated accuracy in
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The ACC/NCDR Risk Score May 4, 2010:1933–5redicting death and/or MI following left main or multives-
el coronary stenting (9,10). A risk model limited to 3
ndependent pre-operative variables including age, ejection
raction, and serum creatinine (ACEF score) has demon-
trated similar or better accuracy and calibration when
ompared with the more complex EuroSCORE or Cleve-
and Clinic score for determining mortality risk following
lective coronary bypass surgery (11). The ACEF, modified
CEF (incorporates creatinine clearance rather than serum
reatinine level), and the EuroSCORE have all been com-
ined with the SYNTAX angiographic lesion complexity
core in an effort to improve predictive accuracy for mortal-
ty and major adverse cardiovascular or cerebrovascular
vents (MACCE) following multivessel PCI (12). The
nclusion of EuroSCORE into a SYNTAX score-based
odel significantly improved prediction of mortality com-
ared with SYNTAX score alone in patients undergoing
CI for left main coronary disease (13).
Angiographic variables with discriminative power for
redicting angiographic and/or clinical procedural success
ave included the presence of left main, proximal left
nterior descending, multivessel coronary artery obstruc-
ions, or angiographic thrombus, as well as objective mea-
urement of left ventricular ejection fraction (4–7). The
YNTAX score, which combines 12 angiographic variables,
s best correlated with the composite end point of MACCE
death, MI, stroke, and repeat revascularization) to 1 or 2
ears following PCI and has limited capacity to predict
ortality except at extremes (highest tertile score 33)
14,15). Recent data suggest that the clinical SYNTAX
core that represents the product of SYNTAX score 
odified ACEF score (age/ejection fraction 1 for each 10
l of creatinine clearance reduction 60 ml/min/1.73 m2 )
s superior in predicting MACCE and mortality at 1 and 5
ears following PCI compared with either the standard
YNTAX or ACEF scores (12). Furthermore, no added
redictive advantage was provided by combining the SYN-
AX score with the more detailed patient-based Euro-
CORE when compared with the clinical SYNTAX score.
he ACC/NCDR Model
he prospectively validated risk model described by Peter-
on et al. (16), in this issue of the Journal, will provide useful
nformation to practicing cardiovascular physicians, health
are institutions, policy makers, and the research commu-
ity. Both full and abbreviated ACC/NCDR models accu-
ately and reliably predict the risk of in-hospital death for
ubjects with or without ST-segment elevation myocardial
nfarction (STEMI) who undergo PCI. In addition, this
odel accurately predicts risk of death to 30 days following
CI in a Medicare population. Although the ACC/NCDR
ppears to provide an “ideal” infrastructure from which to
erive procedural risk (16,17), participation in ACC/
CDR is voluntary, and thus, may include disproportionateepresentation from larger centers, which possess adequate tesources for participation. Lower volume centers, many of
hom were created under the auspice of providing primary
CI for STEMI (and therefore perform a disproportionate
elative percentage of primary rather than elective PCI) may
e under-represented. In the context that both operator and
ospital volumes have been inversely correlated with mor-
ality following primary PCI in STEMI (18) and that
nstitutional volume strata have been correlated inversely
ith the incidence of death or MI following drug-eluting
tent deployment (19), the ACC/NCDR analysis may
eflect a “volume credentialing” process. Although no asso-
iation between site-level procedural volume and in-hospital
ortality could be demonstrated among participating cen-
ers, analysis of risk for death by coronary bypass surgical
tatus (onsite vs. offsite) is not provided (20).
Peterson et al. (16) observe an apparent “paradox” in the
elationship of patient risk to mortality across the develop-
ent and validation cohorts. Specifically, a reduction in
ortality over time in the second prospective validation
ohort (compared with the development and first validation
ohorts) is observed despite an apparent increased risk
rofile (higher rate of pre-procedural Thrombolysis In
yocardial Infarction flow grade 0) in the second validation
ohort. This observation suggests a trend towards improved
CI mortality over time despite an increased risk profile.
he interplay of practice, process of care, and outcomes is
omplex and may be influenced by: 1) declining door-to-
alloon/treatment times in STEMI patients; 2) increased
tilization of pre-PCI pharmacotherapies, including oral
lopidogrel loading and high-dose statins; 3) varied com-
osition of operators and/or hospital volume status and
utcomes for the 608 centers which contributed to the
econd validation cohort; 4) improved patient selection or
etter “up-coding” of risk factors; and 5) play of chance.
nfortunately, additional insights are not provided.
The observation that angiographic characteristics provide
ittle additional information in regards to predicting mor-
ality is consistent with prior studies (4). Although the
uthors suggest utility of their model to provide patient-
pecific risks during the informed consent process (before
atheterization), they have excluded patients who had cath-
terization but no PCI from analysis. As pre-catheterization
ariables are identified prior to catheterization when the
atient is not known to be having a PCI, the subsequent
imitation of analysis to those subjects having a PCI creates a
ohort that may be more uniform with respect to angiographic
eatures than the pre-catheterization population. Therefore,
he “pre-cath” risk score may be applied to a population
patients who subsequently have PCI) that cannot be
efinitively identified prior to catheterization. Given the
roportional disparity between the performance of PCI
ollowing coronary angiography in elective (less than one-
alf) versus STEMI (90%) procedures, the relative per-
ormance of a model based on pre-catheterization charac-
eristics may be different.
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May 4, 2010:1933–5 The ACC/NCDR Risk ScoreFinally, analysis of mortality to 30 days post-PCI in the
edicare population illustrates several points. First, limiting
he time course for observation to in-hospital may be subop-
imal and subject to gaming through early discharge of com-
licated patients to post-hospital care facilities. Such practice
an effectively reduce both hospital length of stay as well as
n-hospital mortality. Extending the time course for observa-
ion to 30 days allows capture of early readmissions and/or
eaths that may be related to either complications of the index
rocedure and/or inadequately treated comorbid conditions.
ndeed, readmission following hospital discharge was observed
n 19.6% of all Medicare patients, including 14.6% of those
ndergoing PCI (21,22). The lower rate of readmission to 30
ays following PCI has been ascribed to the younger age and
enerally better health of those elderly individuals who are
elected for PCI (21). In this context, the 48% relative increase
n mortality from the time of hospital discharge (1.99%) to 30
ays (2.94%) among the 204,111 post-PCI Medicare patients
eported by Peterson et al. (16) is insightful and illustrates the
mportance of extending procedural outcomes analyses beyond
ospital discharge.
In conclusion, Peterson et al. (16) have constructed and vali-
ated a simple additive integer score model that accurately
redicts the risk of in-hospital death following either elective or
rimary PCI. The abbreviated 8-variable model accurately
redicts the risk of death to 30 days post-PCI in Medicare
atients. Although one would expect the ACC/NCDR Cath-
CI risk model to be rapidly assimilated into clinical practice,
he practice of PCI continues to evolve. An increasing propor-
ion of patients, particularly outside of the U.S., is having
day-case” (same-day discharge) PCI via radial artery access
23). The application and validation of the ACC/NCDR
athPCI risk model in this population awaits definition.
urthermore, the potential for the ACC/NCDR risk score to
rovide complementary and/or incremental prognostic informa-
ion to that provided by either the standard SYNTAX score, the
YNTAX–EuroSCORE combined model, or the clinical SYN-
AX score should be evaluated. Finally, any potential prognostic
enefit of combining models to more comprehensively address
CI risk must be weighed against the number of variables
nvolved and the consequent complexity of use.
eprint requests and correspondence: Dr. Dean J. Kereiakes,
he Lindner Research Center, 2123 Auburn Avenue, Suite 424,
incinnati, Ohio 45219. E-mail: lindner@thechristhospital.com.
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